We are pleased to announce that our DeepChek® Assay 13-Plex KB Drug Susceptibility Testing, intended to be used for Tuberculosis Drug Resistance assessment through NGS sequencing, is now CE-IVD marked !

ABL DIAGNOSTICS S.A.

42, rue Olivier Métra – Bat E1

75020, PARIS FRANCE

Phone : +33 145 061 574

Email :

contact@abldiagnostics.com

Email 2 :

fauvet-girel@ablsa.com

Scroll to Top